Clonal composition of neuroantigen-specific CD8+ and CD4+ T-cells in multiple sclerosis

Journal of Neuroimmunology

Volumn 234, Issue 1-2, 2011, Pages 131-140

  Biegler, Brian W ^a,c   Yan, Shirley X ^a   Ortega, Sterling B ^a   Tennakoon, Deepani K ^a   Racke, Michael K ^b   Karandikar, Nitin J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

CD4; CD8; CDR3; Multiple sclerosis; Myelin; TCR

Indexed keywords

BRAIN ANTIGEN; MYELIN BASIC PROTEIN; PROTEOLIPID PROTEIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ADULT; AMINO ACID SEQUENCE; ANTIGEN DETECTION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SELECTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE LOCUS; HUMAN; LEUKAPHERESIS; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA TRANSCRIPTION; SEQUENCE HOMOLOGY; SEX DIFFERENCE; UNINDEXED SEQUENCE;

ADULT; ANTIBODIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CLONING, MOLECULAR; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; MYELIN PROTEOLIPID PROTEIN; MYELIN SHEATH; RECEPTORS, ANTIGEN, T-CELL;

EID: 79955666022     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.02.001     Document Type: Article

References (45)

1. Babbe H., Roers A., Waisman A., Lassmann H., Goebels N., Hohlfeld R., Friese M., Schroder R., Deckert M., Schmidt S., Ravid R., Rajewsky K. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 2000, 192:393-404.
2. Barcellos L.F., Sawcer S., Ramsay P.P., Baranzini S.E., Thomson G., Briggs F., Cree B.C., Begovich A.B., Villoslada P., Montalban X., Uccelli A., Savettieri G., Lincoln R.R., DeLoa C., Haines J.L., Pericak-Vance M.A., Compston A., Hauser S.L., Oksenberg J.R. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum. Mol. Genet. 2006, 15:2813-2824.
3. Batliwalla F., Monteiro J., Serrano D., Gregersen P.K. Oligoclonality of CD8+ T cells in health and disease: aging, infection, or immune regulation?. Hum. Immunol. 1996, 48:68-76.
4. Baughman E.J., Mendoza J.P., Ortega S.B., Ayers C.L., Greenberg B.M., Frohman E.M., Karandikar N.J. Neuroantigen-specific CD8+ regulatory T-cell function is deficient during acute exacerbation of multiple sclerosis. J. Autoimmun. 2011, 36:115-124.
5. Biegler B.W., Yan S.X., Ortega S.B., Tennakoon D.K., Racke M.K., Karandikar N.J. Glatiramer acetate (GA) therapy induces a focused, oligoclonal CD8+ T-cell repertoire in multiple sclerosis. J. Neuroimmunol. 2006, 180:159-171.
6. Bourdette D.N., Whitham R.H., Chou Y.K., Morrison W.J., Atherton J., Kenny C., Liefeld D., Hashim G.A., Offner H., Vandenbark A.A. Immunity to TCR peptides in multiple sclerosis. I. Successful immunization of patients with synthetic V beta 5.2 and V beta 6.1 CDR2 peptides. J. Immunol. 1994, 152:2510-2519.
7. Crawford M.P., Yan S.X., Ortega S.B., Mehta R.S., Hewitt R.E., Price D.A., Stastny P., Douek D.C., Koup R.A., Racke M.K., Karandikar N.J. High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 2004, 103:4222-4231.
8. Douek D.C., Betts M.R., Brenchley J.M., Hill B.J., Ambrozak D.R., Ngai K.L., Karandikar N.J., Casazza J.P., Koup R.A. A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape. J. Immunol. 2002, 168:3099-3104.
9. Einstein E.R., Robertson D.M., Dicaprio J.M., Moore W. The isolation from bovine spinal cord of a homogeneous protein with encephalitogenic activity. J. Neurochem. 1962, 9:353-361.
10. Gran B., Gestri D., Sottini A., Quiros Roldan E., Bettinardi A., Signorini S., Primi D., Ballerini C., Taiuti R., Amaducci L., Massacesi L. Detection of skewed T-cell receptor V-beta gene usage in the peripheral blood of patients with multiple sclerosis. J. Neuroimmunol. 1998, 85:22-32.
11. Gregory S.G., Schmidt S., Seth P., Oksenberg J.R., Hart J., Prokop A., Caillier S.J., Ban M., Goris A., Barcellos L.F., Lincoln R., McCauley J.L., Sawcer S.J., Compston D.A., Dubois B., Hauser S.L., Garcia-Blanco M.A., Pericak-Vance M.A., Haines J.L. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat. Genet. 2007, 39:1083-1091.
12. Gutcher I., Becher B. APC-derived cytokines and T cell polarization in autoimmune inflammation. J. Clin .Invest. 2007, 117:1119-1127.
13. Hafler D.A., Saadeh M.G., Kuchroo V.K., Milford E., Steinman L. TCR usage in human and experimental demyelinating disease. Immunol. Today 1996, 17:152-159.
14. Hafler D.A., Compston A., Sawcer S., Lander E.S., Daly M.J., De Jager P.L., de Bakker P.I., Gabriel S.B., Mirel D.B., Ivinson A.J., Pericak-Vance M.A., Gregory S.G., Rioux J.D., McCauley J.L., Haines J.L., Barcellos L.F., Cree B., Oksenberg J.R., Hauser S.L. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 2007, 357:851-862.
15. Huseby E.S., Liggitt D., Brabb T., Schnabel B., Ohlen C., Goverman J. A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J. Exp. Med. 2001, 194:669-676.
16. Jacobsen M., Cepok S., Quak E., Happel M., Gaber R., Ziegler A., Schock S., Oertel W.H., Sommer N., Hemmer B. Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients. Brain 2002, 125:538-550.
17. Junker A., Ivanidze J., Malotka J., Eiglmeier I., Lassmann H., Wekerle H., Meinl E., Hohlfeld R., Dornmair K. Multiple sclerosis: T-cell receptor expression in distinct brain regions. Brain 2007, 130:2789-2799.
18. Karandikar N.J., Crawford M.P., Yan X., Ratts R.B., Brenchley J.M., Ambrozak D.R., Lovett-Racke A.E., Frohman E.M., Stastny P., Douek D.C., Koup R.A., Racke M.K. Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis. J. Clin. Invest. 2002, 109:641-649.
19. Kotzin B.L., Karuturi S., Chou Y.K., Lafferty J., Forrester J.M., Better M., Nedwin G.E., Offner H., Vandenbark A.A. Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA 1991, 88:9161-9165.
20. Laplaud D.A., Ruiz C., Wiertlewski S., Brouard S., Berthelot L., Guillet M., Melchior B., Degauque N., Edan G., Brachet P., Damier P., Soulillou J.P. Blood T-cell receptor beta chain transcriptome in multiple sclerosis. Characterization of the T cells with altered CDR3 length distribution. Brain 2004, 127:981-995.
21. Lebar R., Lubetzki C., Vincent C., Lombrail P., Boutry J.M. The M2 autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membrane. Clin. Exp. Immunol. 1986, 66:423-434.
22. Lefranc M.P. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 2001, 29:207-209.
23. Lefranc M.P. IMGT, The International ImMunoGeneTics Information System, http://imgt.cines.fr. Meth. Mol. Biol. 2004, 248:27-49.
24. Li Y., Uccelli A., Laxer K.D., Jeong M.C., Vinters H.V., Tourtellotte W.W., Hauser S.L., Oksenberg J.R. Local-clonal expansion of infiltrating T lymphocytes in chronic encephalitis of Rasmussen. J. Immunol. 1997, 158:1428-1437.
25. Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H., Langer-Gould A., Strober S., Cannella B., Allard J., Klonowski P., Austin A., Lad N., Kaminski N., Galli S.J., Oksenberg J.R., Raine C.S., Heller R., Steinman L. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 2002, 8:500-508.
26. Martin R., McFarland H.F., McFarlin D.E. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 1992, 10:153-187.
27. Matsumoto Y., Yoon W.K., Jee Y., Fujihara K., Misu T., Sato S., Nakashima I., Itoyama Y. Complementarity-determining region 3 spectratyping analysis of the TCR repertoire in multiple sclerosis. J. Immunol. 2003, 170:4846-4853.
28. Monteiro J., Hingorani R., Peroglizzi R., Apatoff B., Gregersen P.K. Oligoclonality of CD8+ T cells in multiple sclerosis. Autoimmunity 1996, 23:127-138.
29. Muraro P.A., Cassiani-Ingoni R., Chung K., Packer A.N., Sospedra M., Martin R. Clonotypic analysis of cerebrospinal fluid T cells during disease exacerbation and remission in a patient with multiple sclerosis. J. Neuroimmunol. 2006, 171:177-183.
30. Musette P., Bequet D., Delarbre C., Gachelin G., Kourilsky P., Dormont D. Expansion of a recurrent V beta 5.3+ T-cell population in newly diagnosed and untreated HLA-DR2 multiple sclerosis patients. Proc. Natl. Acad. Sci. USA 1996, 93:12461-12466.
31. Pettinelli C.B., McFarlin D.E. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes. J. Immunol. 1981, 127:1420-1423.
32. Renno T., Krakowski M., Piccirillo C., Lin J.Y., Owens T. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. J. Immunol. 1995, 154:944-953.
33. Ria F., van den Elzen P., Madakamutil L.T., Miller J.E., Maverakis E., Sercarz E.E. Molecular characterization of the T cell repertoire using immunoscope analysis and its possible implementation in clinical practice. Curr. Mol. Med. 2001, 1:297-304.
34. Skulina C., Schmidt S., Dornmair K., Babbe H., Roers A., Rajewsky K., Wekerle H., Hohlfeld R., Goebels N. Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc. Natl. Acad. Sci. USA 2004, 101:2428-2433.
35. Somma P., Ristori G., Battistini L., Cannoni S., Borsellino G., Diamantini A., Salvetti M., Sorrentino R., Fiorillo M.T. Characterization of CD8+ T cell repertoire in identical twins discordant and concordant for multiple sclerosis. J. Leukoc. Biol. 2007, 81:696-710.
36. Steinman L. Myelin-specific CD8 T cells in the pathogenesis of experimental allergic encephalitis and multiple sclerosis. J. Exp. Med. 2001, 194:F27-30.
37. Striebich C.C., Falta M.T., Wang Y., Bill J., Kotzin B.L. Selective accumulation of related CD4+ T cell clones in the synovial fluid of patients with rheumatoid arthritis. J. Immunol. 1998, 161:4428-4436.
38. Sun D., Whitaker J.N., Huang Z., Liu D., Coleclough C., Wekerle H., Raine C.S. Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J. Immunol. 2001, 166:7579-7587.
39. Tennakoon D.K., Mehta R.S., Ortega S.B., Bhoj V., Racke M.K., Karandikar N.J. Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple sclerosis. J. Immunol. 2006, 176:7119-7129.
40. Traugott U., Reinherz E.L., Raine C.S. Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science 1983, 219:308-310.
41. Tuohy V.K., Lu Z.J., Sobel R.A., Laursen R.A., Lees M.B. A synthetic peptide from myelin proteolipid protein induces experimental allergic encephalomyelitis. J. Immunol. 1988, 141:1126-1130.
42. Wekerle H. Immunopathogenesis of multiple sclerosis. Acta. Neurol. Napoli. 1991, 13:197-204.
43. Wu H.D., Maurer M.S., Friedman R.A., Marboe C.C., Ruiz-Vazquez E.M., Ramakrishnan R., Schwartz A., Tilson M.D., Stewart A.S., Winchester R. The lymphocytic infiltration in calcific aortic stenosis predominantly consists of clonally expanded T cells. J. Immunol. 2007, 178:5329-5339.
44. Wucherpfennig K.W., Newcombe J., Li H., Keddy C., Cuzner M.L., Hafler D.A. T cell receptor V alpha-V beta repertoire and cytokine gene expression in active multiple sclerosis lesions. J. Exp. Med. 1992, 175:993-1002.
45. York N.R., Mendoza J.P., Ortega S.B., Benagh A., Tyler A.F., Firan M., Karandikar N.J. Immune regulatory CNS-reactive CD8+T cells in experimental autoimmune encephalomyelitis. J. Autoimmun. 2010, 35:33-44.